These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10509549)

  • 1. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam.
    White WB; Radford MJ; Gonzalez FM; Weed SG; McCabe EJ; Katz AM
    J Am Coll Cardiol; 1988 May; 11(5):1118-23. PubMed ID: 2895780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
    Taylor AA; Mangoo-Karim R; Ballard KD; Luther RR; Pool JL
    J Clin Pharmacol; 1999 May; 39(5):471-9. PubMed ID: 10234594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
    Mathur VS; Swan SK; Lambrecht LJ; Anjum S; Fellmann J; McGuire D; Epstein M; Luther RR
    Crit Care Med; 1999 Sep; 27(9):1832-7. PubMed ID: 10507606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure.
    Piltz JR; Stone RA; Boike S; Everitt DE; Shusterman NH; Audet P; Zariffa N; Jorkasky DK
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):203-16. PubMed ID: 9671428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenoldopam infusion for the treatment of postoperative hypertension.
    Goldberg ME; Cantillo J; Nemiroff MS; Subramoni J; Muñoz R; Torjman M; Schieren H
    J Clin Anesth; 1993; 5(5):386-91. PubMed ID: 8105829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.
    Brogden RN; Markham A
    Drugs; 1997 Oct; 54(4):634-50. PubMed ID: 9339965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers.
    Prielipp RC; Wall MH; Groban L; Tobin JR; Fahey FH; Harkness BA; Stump DA; James RL; Cannon MA; Bennett J; Butterworth J
    Anesth Analg; 2001 Jul; 93(1):45-52. PubMed ID: 11429337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of intravenous fenoldopam in healthy, awake cats.
    O'Neill KE; Labato MA; Court MH
    J Vet Pharmacol Ther; 2016 Apr; 39(2):202-4. PubMed ID: 26763106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.
    Tumlin JA; Dunbar LM; Oparil S; Buckalew V; Ram CV; Mathur V; Ellis D; McGuire D; Fellmann J; Luther RR
    Acad Emerg Med; 2000 Jun; 7(6):653-62. PubMed ID: 10905644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary pharmacokinetics and cardiovascular effects of fenoldopam continuous rate infusion in six healthy dogs.
    Bloom CA; Labato MA; Hazarika S; Court MH
    J Vet Pharmacol Ther; 2012 Jun; 35(3):224-30. PubMed ID: 21732952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.
    Munger MA; Rutherford WF; Anderson L; Hakki AI; Gonzalez FM; Bednarczyk EM; Emmanuel G; Weed SG; Panacek EA; Green JA
    Crit Care Med; 1990 May; 18(5):502-4. PubMed ID: 1970283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.
    O'Connell DP; Ragsdale NV; Boyd DG; Felder RA; Carey RM
    Hypertension; 1997 Jan; 29(1 Pt 1):115-22. PubMed ID: 9039090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
    Smith WB; Marbury TC; Komjathy SF; Sumeray MS; Williams GC; Hu MY; Mould DR
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1385-94. PubMed ID: 22457015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair.
    Gilbert TB; Hasnain JU; Flinn WR; Lilly MP; Benjamin ME
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):31-6. PubMed ID: 11452334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.
    Weber RR; McCoy CE; Ziemniak JA; Frederickson ED; Goldberg LI; Murphy MB
    Br J Clin Pharmacol; 1988 Jan; 25(1):17-21. PubMed ID: 2897206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing contrast-induced nephropathy with fenoldopam.
    Hunter DW; Chamsuddin A; Bjarnason H; Kowalik K
    Tech Vasc Interv Radiol; 2001 Mar; 4(1):53-6. PubMed ID: 11981789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1986 Jan; 21(1):53-61. PubMed ID: 2868748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.